Cargando…

Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine

Detalles Bibliográficos
Autores principales: Peng, Hua, Fu, Yang-Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902270/
https://www.ncbi.nlm.nih.gov/pubmed/35260791
http://dx.doi.org/10.1038/s41422-022-00634-w
_version_ 1784664565393391616
author Peng, Hua
Fu, Yang-Xin
author_facet Peng, Hua
Fu, Yang-Xin
author_sort Peng, Hua
collection PubMed
description
format Online
Article
Text
id pubmed-8902270
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-89022702022-03-08 Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine Peng, Hua Fu, Yang-Xin Cell Res Research Highlight Springer Singapore 2022-03-08 2022-04 /pmc/articles/PMC8902270/ /pubmed/35260791 http://dx.doi.org/10.1038/s41422-022-00634-w Text en © The Author(s) under exclusive licence to Center for Excellence in Molecular Cell Science, CAS 2022
spellingShingle Research Highlight
Peng, Hua
Fu, Yang-Xin
Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine
title Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine
title_full Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine
title_fullStr Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine
title_full_unstemmed Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine
title_short Innovative adjuvant augments potency of a SARS-CoV-2 subunit vaccine
title_sort innovative adjuvant augments potency of a sars-cov-2 subunit vaccine
topic Research Highlight
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902270/
https://www.ncbi.nlm.nih.gov/pubmed/35260791
http://dx.doi.org/10.1038/s41422-022-00634-w
work_keys_str_mv AT penghua innovativeadjuvantaugmentspotencyofasarscov2subunitvaccine
AT fuyangxin innovativeadjuvantaugmentspotencyofasarscov2subunitvaccine